SPAXIZA
Live / Applied — Fourth extension granted (statement of use) (as of 10 Feb 2026)
What this means for you
Not registered yet, but its 14 Apr 2023 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97888688
- Mark type
- Stylized text
- Filed
- 14 Apr 2023
- Published for opposition
- 19 Dec 2023
- Attorney of record
- Maury M. Tepper, III
Goods and services
- Class 005 — Pharmaceuticals: Anti-epileptic pharmaceutical preparations; Pharmaceutical preparations for the treatment and prevention of seizures and spasms
Owner
- Fidelity Biopharma Co., New Haven, CT, US
- Fidelity Biopharma Co., New Haven, CT, US
Prosecution history
- 11 Feb 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 10 Feb 2026 — SOU EXTENSION 4 GRANTED
- 10 Feb 2026 — SOU EXTENSION 4 FILED
- 10 Feb 2026 — SOU TEAS EXTENSION RECEIVED
- 09 Aug 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 08 Aug 2025 — SOU EXTENSION 3 GRANTED
- 08 Aug 2025 — SOU EXTENSION 3 FILED
- 08 Aug 2025 — SOU TEAS EXTENSION RECEIVED
- 05 Feb 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 05 Feb 2025 — SOU EXTENSION 2 GRANTED
- 04 Feb 2025 — SOU EXTENSION 2 FILED
- 04 Feb 2025 — SOU TEAS EXTENSION RECEIVED
- 02 Aug 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 02 Aug 2024 — SOU EXTENSION 1 GRANTED
- 02 Aug 2024 — SOU EXTENSION 1 FILED